Use of the prostate‐specific antigen test in the U.S. for men age 30 to 64 in 2011 to 2017 using a large commercial claims database: Implications for practice interventions

BACKGROUND: Given the public health relevance of PSA‐based screening, various professional organizations have issued recommendations on the use of the PSA test to screen for prostate cancer in different age groups. AIM: Using a large commercial claims database, we aimed to determine the most recent...

Descripción completa

Detalles Bibliográficos
Autores principales: Shahangian, Shahram, Sharma, Krishna P., Fan, Lin, Siegel, David A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8388177/
https://www.ncbi.nlm.nih.gov/pubmed/33934557
http://dx.doi.org/10.1002/cnr2.1365

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8388177/
https://www.ncbi.nlm.nih.gov/pubmed/33934557
http://dx.doi.org/10.1002/cnr2.1365

Ejemplares similares